Avid Bioservices Inc. (Nasdaq: CDMO) named Timothy Compton chief commercial officer.
He replaces Tracy Kinjerski, who’s left the contract drug maker.
Compton was previously senior director of sales at Cambrex Corp., a contract maker of small molecules.
For more on Avid’s growth plans and its recent executive shifts, see the Jan.27 print edition of the Business Journal.
